These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2739074)

  • 1. [Clinical evaluation of radioimmunoscintigraphy using a I-131 anti CEA and CA 19-9 monoclonal antibodies cocktail (IMACIS-1)].
    Takahashi T; Tsujino D; Kato Y; Wada Y; Someya K; Itagaki K; Imanishi Y; Ishikawa T; Sakaki T; Sasaki Y
    Gan No Rinsho; 1989 Jun; 35(7):828-33. PubMed ID: 2739074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of immunoscintigraphy with 131I anti-CEA and 131I anti-CA 19-9 monoclonal antibody cocktail (IMACIS-1)--report of the phase II study].
    Sasaki Y; Inoue T; Oriuchi N; Mitsuhashi N; Nagai T; Igarashi H; Tsujino D; Takahashi T; Sakaki T; Okazaki A
    Kaku Igaku; 1990 Apr; 27(4):349-62. PubMed ID: 2198368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental study of tumor detection using 131I-labeled F (ab)2 fragments of monoclonal antibodies to CA 19-9 and CEA (IMACIS-1)].
    Mitsuhashi N; Kazumoto T; Nakayama Y; Sugiyama S; Yamakawa M; Yonome I; Nakamura Y; Nagai T; Niibe H
    Gan No Rinsho; 1989 Dec; 35(15):1753-8. PubMed ID: 2691716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer].
    Campos Villarino LM; Pajares Vinardell M; Freire Macias JM; Vale Gonsalves EI; Millán Núñez-Cortés J; Senra Varela A
    An Med Interna; 1991 Aug; 8(8):377-81. PubMed ID: 1768746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A fundamental study of immunoscintigraphy with 131I-labeled anti-CA 19-9 and anti-CEA monoclonal antibodies--imaging of tumor-bearing mice by IMACIS-1 and cell ELISA with human tumor cells].
    Nogami T; Miura H; Ohmi S; Kazahaya Y
    Kaku Igaku; 1990 May; 27(5):427-36. PubMed ID: 2395226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125.
    Baum RP; Lorenz M; Hottenrott C; Albrecht M; Senekowitsch R; Happ J; Hertel A; Spitz J; Hör G
    Int J Biol Markers; 1988; 3(3):177-84. PubMed ID: 3230337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of pancreatic and colorectal cancer using antibody fragments: a preliminary evaluation.
    Ballantyne KC; Perkins AC; Selby C; Wastie ML; Hardcastle JD
    Eur J Surg Oncol; 1988 Oct; 14(5):393-8. PubMed ID: 3181442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')2 (FO23C5) in CEA serum-negative colorectal cancer patients.
    Roselli M; Guadagni F; Buonomo O; Belardi A; Vittorini V; Cavazzana A; Spagnoli LG; Cipriani C; Casciani CU
    Anticancer Res; 1996; 16(2):883-9. PubMed ID: 8687145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunodetection of cancer of gastrointestinal tract and liver metastasis with I-131 anti-CEA and I-131 anti-CA19-9 monoclonal antibody cocktail (IMACIS-1).
    Naruki Y; Urita Y; Miyachi Y; Otsuka S; Noguchi M; Kogure T; Sasaki Y
    Ann Nucl Med; 1994 Aug; 8(3):163-9. PubMed ID: 7811557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report.
    Zanin DE; van Dongen A; Hoefnagel CA; Bruning PF
    J Nucl Med; 1990 Nov; 31(11):1854-5. PubMed ID: 2231001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical application of radioimmunolocalization in colorectal cancer].
    Germà JR; Alvarez I; Carrió I; Estorch M; Bernà L; Martínez-Duncker C; Marcuello E; Nogueras FM
    Med Clin (Barc); 1990 Mar; 94(9):325-8. PubMed ID: 2329866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Scintigraphic detection of malignancies with radioactively labelled tumor antibodies. Clinical results based on immunohistochemical research].
    Biersack HJ; Bockisch A; Vogel J; Oehr P; Hansen HH; Hartlapp J; Biltz H; Jaeger N; Bellmann O
    Dtsch Med Wochenschr; 1987 Feb; 112(9):341-4. PubMed ID: 2434296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new biomarker in monitoring breast cancer: CA 549.
    Beveridge RA; Chan DW; Bruzek D; Damron D; Bray KR; Gaur PK; Ettinger DS; Rock RC; Shurbaji MS; Kuhajda FP
    J Clin Oncol; 1988 Dec; 6(12):1815-21. PubMed ID: 3058875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.
    Sutherland R; Buchegger F; Schreyer M; Vacca A; Mach JP
    Cancer Res; 1987 Mar; 47(6):1627-33. PubMed ID: 3545451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
    Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
    Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour markers in colorectal cancer.
    Roberts PJ
    Scand J Gastroenterol Suppl; 1988; 149():50-8. PubMed ID: 3201159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-CEA immunoscintigraphy in postoperative follow-up of tumor patients. Differentiated use of various monoclonal antibody preparations].
    Leitha T; Baur M; Steger G; Dudczak R
    Wien Klin Wochenschr; 1990 Sep; 102(17):503-9. PubMed ID: 2264338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of immunoscintigraphy in colorectal cancer--results of 5 years' clinical experiences.
    Hölting T; Schlag P; Georgi P
    Eur J Surg Oncol; 1990 Aug; 16(4):312-8. PubMed ID: 2199223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of tumor markers CA 15-3 and CEA in breast cancer].
    Buck I; Lindner C; Böge K; Kitschke HJ
    Arch Gynecol Obstet; 1989; 245(1-4):674-7. PubMed ID: 2802753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.